Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
ABOUT THIS PAGE
82
PharmaCompass offers a list of 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride manufacturer or 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride manufacturer or 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride supplier.
PharmaCompass also assists you with knowing the 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride API Price utilized in the formulation of products. 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride API Price is not always fixed or binding as the 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride Price is obtained through a variety of data sources. The 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo, including repackagers and relabelers. The FDA regulates 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo supplier is an individual or a company that provides 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo active pharmaceutical ingredient (API) or 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo finished formulations upon request. The 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo suppliers may include 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo API manufacturers, exporters, distributors and traders.
click here to find a list of 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo DMF (Drug Master File) is a document detailing the whole manufacturing process of 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo active pharmaceutical ingredient (API) in detail. Different forms of 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo DMFs exist exist since differing nations have different regulations, such as 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo DMF submitted to regulatory agencies in the US is known as a USDMF. 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo USDMF includes data on 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo suppliers with USDMF on PharmaCompass.
1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo GMP manufacturer or 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo GMP API supplier for your needs.
A 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo CoA (Certificate of Analysis) is a formal document that attests to 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo's compliance with 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo specifications and serves as a tool for batch-level quality control.
1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo CoA mostly includes findings from lab analyses of a specific batch. For each 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo may be tested according to a variety of international standards, such as European Pharmacopoeia (1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo EP), 1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1H-Imidazolium,1,3-bis[2,6-bis(1-methylethyl)phenyl]-, chloride (9CI);1,3-Bis(2,6-diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidenemonohydrochloride;1,3-Bis(2,6-diisopropylphenyl)-1H-imidazolium chloride;1,3-Bis[2,6-bis(1-methylethyl)phenyl]-1H-imidazo USP).
